Junkosha announced today that it is awarding Creo Medical founder and CTO Chris Hancock with a $25,000 prize as the winner of its inaugural Technology Innovator of the Year Awards.
The U.K.-based company has created an advanced energy multimodality instrument developed for flexible endoscopy. According to Junkosha, Creo Medical’s technology combines the benefits of bipolar RF and super high-frequency microwave energy to provide the ability to dissect, resect, coagulate and inject in a single device — producing results that could reduce cancer recurrence.
“Chris’ breakthrough technology holds the potential to transform the point of treatments for a range of cancers. Overall, Chris’ achievement is one we can use as a yardstick to measure others in future years,” said Joe Rowan, Junkosha’s president and CEO in the U.S. and Europe.
Said Junkosha CEO Mamoru Sogo: “We believe that enabling innovators, like Creo Medical, is central to the philosophy behind the Junkosha brand as we continually look to advance the next generation of technology for a better future. As part of the plans to raise awareness of our new brand internationally, the awards program delivers a tangible commitment to our values.”
